Patterns of response to anti-PD-1 treatment: an exploratory comparison of four radiological response criteria and associations with overall survival in metastatic melanoma patients-Reference-Cited by-同舟云学术

Patterns of response to anti-PD-1 treatment: an exploratory comparison of four radiological response criteria and associations with overall survival in metastatic melanoma patients

Published:2016-10-04 Issue:10 Volume:115 Page:1186-1192
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Khoja Leila,Kibiro Minnie,Metser Ur,Gedye Craig,Hogg David,Butler Marcus O,Atenafu Eshetu G,Joshua Anthony M

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/bjc2016308.pdf

Reference21 articles.

1. Chiou VL, Burotto M (2015) Pseudoprogression and immune-related response in solid tumors. J Clin Oncol 33 (31): 3541–3543.

2. Choi H, Charnsangavej C, de Castro Faria S, Tamm EP, Benjamin RS, Johnson MM, Macapinlac HA, Podoloff DA (2004) CT evaluation of the response of gastrointestinal stromal tumors after imatinib mesylate treatment: a quantitative analysis correlated with FDG PET findings. AJR Am J Roentgenol 183 (6): 1619–1628.

3. Choi H, Charnsangavej C, Faria SC, Macapinlac HA, Burgess MA, Patel SR, Chen LL, Podoloff DA, Benjamin RS (2007) Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: proposal of new computed tomography response criteria. J Clin Oncol 25 (13): 1753–1759.

4. Couzin-Frankel J (2013) Breakthrough of the year 2013. Cancer immunotherapy. Science 342 (6165): 1432–1433.

5. Das R, Verma R, Sznol M, Boddupalli CS, Gettinger SN, Kluger H, Callahan M, Wolchok JD, Halaban R, Dhodapkar MV, Dhodapkar KM (2015) Combination therapy with anti-CTLA-4 and anti-PD-1 leads to distinct immunologic changes in vivo. J Immunol 194 (3): 950–959.

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radiomic analysis of patient and inter-organ heterogeneity in response to immunotherapies and BRAF targeted therapy in metastatic melanoma;2024-04-27

2. Role of enhancement modifications in evaluating tumor response to immunotherapy in metastatic renal cell carcinoma;Tumori Journal;2023-07-28

3. Immune suppressive microenvironment in liver metastases contributes to organ-specific response of immunotherapy in advanced non-small cell lung cancer;Journal for ImmunoTherapy of Cancer;2023-07

4. Different immune contextures underlie tumor site‐specific responses to immune checkpoint blockade in esophageal cancer;Thoracic Cancer;2023-06-20

5. Immune checkpoint inhibitors: Assessment of the performance and the agreement of iRECIST, irRC, and irRECIST;Journal of Cancer Research and Therapeutics;2023-04-07